Lv2
170 积分 2025-02-05 加入
Corticosteroid therapy for treating acute exacerbation of interstitial lung diseases: a systematic review
19天前
已完结
POS0854 BASELINE CHARACTERISTICS OF PATIENTS WITH IMPROVEMENT OR PROGRESSION OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSc-ILD) DURING THE SENSCIS TRIAL
21天前
已关闭
Idiopathic pulmonary fibrosis
21天前
已完结
Acute exacerbation of interstitial lung disease associated with rheumatic disease
23天前
已完结
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
1个月前
已完结
Update of the International Multidisciplinary Classification of the Interstitial Pneumonias: An ERS/ATS Statement
1个月前
已完结
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
2个月前
已完结
Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure
2个月前
已完结
An Update on Patient-Reported Outcomes in Asthma
2个月前
已完结
Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
2个月前
已完结
皖公网安备34019202002308
